Cargando…

Viscoelastometric Testing to Assess Hemostasis of COVID-19: A Systematic Review

Infection by SARS-CoV-2 is associated with a high risk of thrombosis. The laboratory documentation of hypercoagulability and impaired fibrinolysis remains a challenge. Our aim was to assess the potential usefulness of viscoelastometric testing (VET) to predict thrombotic events in COVID-19 patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bareille, Marion, Hardy, Michaël, Douxfils, Jonathan, Roullet, Stéphanie, Lasne, Dominique, Levy, Jerrold H., Stépanian, Alain, Susen, Sophie, Frère, Corinne, Lecompte, Thomas, Mullier, François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072929/ https://www.ncbi.nlm.nih.gov/pubmed/33923851 http://dx.doi.org/10.3390/jcm10081740

Ejemplares similares

Are Viscoelastometric Assays of Old Generation Ready for Disposal? Comment on Volod et al. Viscoelastic Hemostatic Assays: A Primer on Legacy and New Generation Devices. J. Clin. Med. 2022, 11, 860
por: Bareille, Marion, et al.
Publicado: (2023)

Prothrombotic hemostasis disturbances in patients with severe COVID-19: Individual daily data
por: Hardy, Michaël, et al.
Publicado: (2020)

Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study
por: Hardy, Michaël, et al.
Publicado: (2021)

Laboratory evaluation of a new integrative assay to phenotype plasma fibrinolytic system
por: Bareille, Marion, et al.
Publicado: (2022)

Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory
por: Hardy, M., et al.
Publicado: (2020)

Measurement of non-VKA oral anticoagulants versus classic ones: the appropriate use of hemostasis assays
por: Douxfils, Jonathan, et al.
Publicado: (2014)

Hemostasis testing in patients with liver dysfunction: Advantages and caveats
por: Nguyen, Guillaume, et al.
Publicado: (2021)

Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring
por: Susen, Sophie, et al.
Publicado: (2020)

Don't let D-dimer fool you: Elevated D-dimer plasma levels should not imply ‘hyperfibrinolysis’
por: Hardy, M., et al.
Publicado: (2022)

Comparison is not reason: Pitfalls in reporting thrombin generation results in anticoagulated patients
por: Douxfils, Jonathan, et al.
Publicado: (2021)

Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021): From the French working group on perioperative haemostasis (GIHP) and the French study group on thrombosis and haemostasis (GFHT), in collaboration with the French society of anaesthesia and intensive care (SFAR)
por: Godon, Alexandre, et al.
Publicado: (2021)

Thrombin generation, bleeding and hemostasis in humans: Protocol for a scoping review of the literature
por: Shaw, Joseph R., et al.
Publicado: (2023)

Periprocedural Management of Direct Oral Anticoagulants Should Be Guided by Accurate Laboratory Tests
por: Lessire, Sarah, et al.
Publicado: (2016)

Resistance to unfractionated heparin in the ICU: evaluation and management options
por: Levy, Jerrold H., et al.
Publicado: (2023)

Treatment of Achilles Tendinopathy in Recreational Runners with Peritendinous Hyaluronic Acid Injections: A Viscoelastometric, Functional, and Biochemical Pilot Study
por: Gervasi, Marco, et al.
Publicado: (2021)

Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study
por: Godon, Alexandre, et al.
Publicado: (2021)

Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination
por: Douxfils, Jonathan, et al.
Publicado: (2021)

NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments
por: Gillot, Constant, et al.
Publicado: (2021)

Prévention du risque thromboembolique veineux et surveillance de l’hémostase chez les patients hospitalisés pour COVID-19 : propositions réactualisées (avril 2021). Groupe d’intérêt en hémostase périopératoire (GIHP) et groupe d’étude sur l’hémostase et la thrombose (GFHT)
por: Godon, Alexandre, et al.
Publicado: (2021)

Clinical value of early viscoelastometric point‐of‐care testing during postpartum hemorrhage for the prediction of severity of bleeding: A multicenter prospective cohort study in the Netherlands
por: Ramler, Paul I., et al.
Publicado: (2021)

Uninterrupted DOACs Approach for Catheter Ablation of Atrial Fibrillation: Do DOACs Levels Matter?
por: Hardy, Michael, et al.
Publicado: (2022)

Could Daily Monitoring of Fibrin Related Markers Help Suspect a Thrombotic Event in COVID-19 Patients? A Prospective Pilot Study
por: Hardy, Michael, et al.
Publicado: (2021)

Post-SARS-CoV-2 vaccination specific antibody decrease — Thresholds for determining seroprevalence and seroneutralization differ
por: Douxfils, Jonathan, et al.
Publicado: (2021)

Management of Non-Vitamin K Antagonist Oral Anticoagulants in the Perioperative Setting
por: Dincq, Anne-Sophie, et al.
Publicado: (2014)

The Developing Balance of Thrombosis and Hemorrhage in Pediatric Surgery: Clinical Implications of Age-Related Changes in Hemostasis
por: Achey, Meredith A., et al.
Publicado: (2020)

D-dimer Testing in Pulmonary Embolism with a Focus on Potential Pitfalls: A Narrative Review
por: Wauthier, Loris, et al.
Publicado: (2022)

Effects of conjugated estrogen and bazedoxifene on hemostasis and thrombosis in mice
por: Noirrit, Emmanuelle, et al.
Publicado: (2019)

Long-Term Survival, Vascular Occlusive Events and Efficacy Biomarkers of First-Line Treatment of CML: A Meta-Analysis
por: Haguet, Hélène, et al.
Publicado: (2020)

Hemostasis Strategies and Recent Advances in Nanomaterials for Hemostasis
por: Du, Jian, et al.
Publicado: (2023)

Polyphosphate in thrombosis, hemostasis, and inflammation
por: Baker, Catherine J., et al.
Publicado: (2018)

Recent advances in the treatment and prevention of venous thromboembolism in cancer patients: role of the direct oral anticoagulants and their unique challenges
por: Farge, Dominique, et al.
Publicado: (2019)

The edoxaban‐M4 metabolite and measurement of edoxaban by chromogenic assays in human plasma
por: Siriez, Romain, et al.
Publicado: (2022)

The History of Hemostasis
por: Wies, C. H.
Publicado: (1929)

Hemostasis and ageing
por: Mari, Daniela, et al.
Publicado: (2008)

Hematology and Hemostasis
por: Finke, Jürgen, et al.
Publicado: (2008)

The History of Hemostasis
por: Klopp, Edward J.
Publicado: (1930)

The History of Hemostasis
por: Harvey, Samuel C.
Publicado: (1929)

Hibernation and hemostasis
por: De Vrij, Edwin L., et al.
Publicado: (2023)

BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?
por: Haguet, Hélène, et al.
Publicado: (2018)

The role of serology for COVID-19 control: Population, kinetics and test performance do matter
por: Tré-Hardy, Marie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rtbmcibd5lmjdrkuakieot9nmj